New blood biomarker improves cancer risk detection in people with Lynch Syndrome
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can…
Metformin mimics exercise-related metabolic effects in prostate cancer patients
A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise’s core…
CFHR1 could be a new diagnostic marker for IgA nephropathy
Immunoglobulin A (IgA) nephropathy is an autoimmune disease characterized by the deposition of circulating IgA-containing immune complexes (IgA-ICs)…
Healthy thymus gland linked to longer life and immune stability
People with a healthy thymus gland live longer and are less likely to fall ill. In addition, immunotherapies…
New guidance aims to standardize tumor mutational burden in cancer
Immune checkpoint inhibitors have transformed cancer care, yet only a minority of patients respond to monotherapy, and immune-related…
Microscopic sensors could revolutionize diagnosis and monitoring of cancer
Microscopic sensors that are as thin as a strand of hair but capable of taking multiple measurements simultaneously could revolutionize the diagnosis and…
Wholegrain rye changes gut bacteria and lowers inflammation in obesity trial
A 12-week randomized trial found that wholegrain rye did not beat refined wheat for weight loss, but it…
BNP predicts kidney disease progression risk in diabetes patients
The relationship between cardiovascular dysfunction and renal impairment is widely recognized as the cardiorenal interaction, a complex physiological…
Oral semaglutide fails to slow early Alzheimer’s decline in two phase 3 trials
Despite hopes raised by earlier observational studies and biomarker shifts, The Lancet trials found that oral semaglutide did…
New compound targets the neuronal epigenome to treat Alzheimer’s disease
A team from the University of Barcelona has designed and validated in animal models an innovative compound with…
Expanding blood-based Alzheimer’s biomarker research
Dr. Thomas Karikari, an Assistant Professor at the University of Pittsburgh, plays a key role in the creation…
Siemens Healthineers launches brain health research portfolio with first biomarker assays now available
Siemens Healthineers announced today its offerings for brain health research are expanding, with the brain-derived, fully automated Atellica…